{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:26:00Z","timestamp":1707524760790},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,3]]},"DOI":"10.7759\/cureus.29867","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T15:31:37Z","timestamp":1664811097000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrence of Angioimmunoblastic T-cell Lymphoma in a Patient Successfully Treated for Hodgkin\u2019s Lymphoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Syed Alishan","family":"Nasir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simranjit","family":"Johal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Khandpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-99716-2_5","article-title":"Angioimmunoblastic T-cell lymphoma","author":"Yabe M","year":"2019","unstructured":"Yabe M, Dogan A, Horwitz SM, Moskowitz AJ. Angioimmunoblastic T-cell lymphoma. Cancer Treat Res. Querfeld C, Zain J, Rosen S (ed): Springer, Cham; 2019. 176:99-126. 10.1007\/978-3-319-99716-2_5"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28060456","article-title":"Recent advances in diagnosis and therapy of Angioimmunoblastic T cell lymphoma","volume":"28","author":"Mohammed Saleh MF","year":"2021","unstructured":"Mohammed Saleh MF, Kotb A, Abdallah GE, Muhsen IN, El Fakih R, Aljurf M. Recent advances in diagnosis and therapy of Angioimmunoblastic T cell lymphoma. Curr Oncol. 2021, 28:5480-98. 10.3390\/curroncol28060456","journal-title":"Curr Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092585","article-title":"No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases","volume":"9","author":"Xu B","year":"2014","unstructured":"Xu B, Liu P. No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. PLoS One. 2014, 9:e92585. 10.1371\/journal.pone.0092585","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-692541","article-title":"Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma","volume":"129","author":"Lunning MA","year":"2017","unstructured":"Lunning MA, Vose JM. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood. 2017, 129:1095-102. 10.1182\/blood-2016-09-692541","journal-title":"Blood"},{"key":"ref5","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"81","author":"Mahajan RS","year":"2015","unstructured":"Mahajan RS, Vaghani AP, Pasle RK. Angioimmunoblastic T-cell lymphoma. Indian J. 2015, 81:315.","journal-title":"Indian J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba S","year":"2020","unstructured":"Chiba S, Sakata-Yanagimoto M. Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia. 2020, 34:2592-606. 10.1038\/s41375-020-0990-y","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay MP","year":"2017","unstructured":"Dobay MP, Lemonnier F, Missiaglia E, et al.. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin. Haematologica. 2017, 102:e148-51. 10.3324\/haematol.2016.158428","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project","volume":"31","author":"Federico M","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, et al.. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013, 31:240-6. 10.1200\/JCO.2011.37.3647","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"121","author":"Dogan A","year":"2003","unstructured":"Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol. 2003, 121:681-91. 10.1046\/j.1365-2141.2003.04335.x","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08329.x","article-title":"Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP\/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95","volume":"151","author":"Simon A","year":"2010","unstructured":"Simon A, Peoch M, Casassus P, et al.. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP\/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Br J Haematol. 2010, 151:159-66. 10.1111\/j.1365-2141.2010.08329.x","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.061507","article-title":"Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA","volume":"97","author":"Delfau-Larue MH","year":"2012","unstructured":"Delfau-Larue MH, de Leval L, Joly B, et al.. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica. 2012, 97:1594-602. 10.3324\/haematol.2011.061507","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8268","article-title":"Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study","volume":"29","author":"Swerdlow AJ","year":"2011","unstructured":"Swerdlow AJ, Higgins CD, Smith P, et al.. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol. 2011, 29:4096-104. 10.1200\/JCO.2011.34.8268","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)60035-X","article-title":"Hodgkin's lymphoma in adults","volume":"380","author":"Townsend","year":"2012","unstructured":"Townsend, William, and David Linch. Hodgkin's lymphoma in adults. Lancet. 2012, 380:836-47.","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/3.suppl_4.s117","article-title":"Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease","volume":"3 Suppl 4","author":"Henry-Amar M","year":"1992","unstructured":"Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol. 1992, 3 Suppl 4:117-28. 10.1093\/annonc\/3.suppl_4.s117","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.7.2026","article-title":"Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis","volume":"19","author":"Rueffer U","year":"2001","unstructured":"Rueffer U, Josting A, Franklin J, et al.. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol. 2001, 19:2026-32. 10.1200\/JCO.2001.19.7.2026","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/112185-recurrence-of-angioimmunoblastic-t-cell-lymphoma-in-a-patient-successfully-treated-for-hodgkins-lymphoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:12Z","timestamp":1707507612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/112185-recurrence-of-angioimmunoblastic-t-cell-lymphoma-in-a-patient-successfully-treated-for-hodgkins-lymphoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.29867","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,3]]}}}